top of page
Search

VIDEO: Lebrikizumab effective in treating head, neck AD

Writer: Jeremy Visser
Jeremy Visser
Sep 17, 2025
1 min read

According to a recent study, lebrikizumab, a monoclonal antibody targeting IL-13, is effective in treating head and neck atopic dermatitis (AD) and erythema at 16 weeks of treatment.


Comments

bottom of page